How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta-Synthesis of Qualitative Studies.
Melanie Trimmel, Antonia Renner, Alexander Kaltenboeck
PMID 39283006WHAT IT FOUND
People undergoing ketamine for psychiatric problems described treatment as a three-stage journey: anxious hope before, strange or frightening effects during, then relief, disappointment or loss after.
Context and support shaped the experience.
Key findings
01People described ketamine treatment as a three-stage journey, with different concerns before, during, and after sessions.
02The acute experience varied widely, and the environment, staff interaction, and soundscape could influence how it felt.
03When improvement was absent or short-lived, participants sometimes reported disappointment and increased hopelessness.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a synthesis of subjective experience, not a test of whether ketamine works or how long effects last. The included studies varied widely in diagnoses, ketamine dose and route, setting, and whether psychotherapy was given, so the themes cannot be applied to one clinic without checking the local service. Some included papers were case reports or case series, and some reported participant feedback without systematic qualitative analysis. The included studies reflected poorly on the researchers' own influence on the data, which can shape themes. The synthesis mixed participant quotes with study authors' interpretations, so some themes may be partly the authors' framing. The paper does not report a total participant count across the included studies.
Declared interests
The authors declared no conflicts of interest. The supplied text does not state who funded the work.
The easy way to misread this
Do not read the reported improvements in mood, anxiety, suicidality or daily functioning as proof that ketamine works. This paper synthesises subjective experience from heterogeneous qualitative studies and case reports, so it cannot separate the drug's effect from setting, therapy, expectation or natural change.